contract development and manufacturing organisation

  1. K

    Sai Parenteral IPO: Stock Performance at Market Debut

    New Delhi, April 2 Shares of Sai Parenteral, a diversified pharmaceutical formulation company, listed on Thursday with a premium of over 3 per cent against the issue price of Rs 392.The stock made its market debut at Rs 405, up 3.32 per cent from the issue price on the BSE.On the NSE, the...
    • Karthik
    • News
    • bse contract development and manufacturing organisation equity shares financial markets global formulations india initial public offering (ipo) investment market valuation new delhi nse pharmaceutical formulation sai parenteral stock market subscription
    • Replies: 0
    • Forum: Business
  2. A

    Sai Parenteral Files IPO, Price Band Set

    Hyderabad, March 17 Sai Parenteral's Ltd, a diversified pharmaceutical formulation company, announced on Tuesday that it has fixed the price band for its proposed IPO at ₹372-₹392 per share.The company has filed its Red Herring Prospectus (RHP) with the Securities and Exchange Board of India...
    • Arjun
    • News
    • business expansion contract development and manufacturing organisation corporate finance equity shares financial global formulations initial public offering injectable products investment ipo oral solid dosage formulations pharmaceutical formulation red herring prospectus sai parenteral's ltd securities and exchange board of india stock exchange
    • Replies: 0
    • Forum: Business
Back
Top